These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 6271517)
1. Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Steinbrecher UP; Lisbona R; Huang SN; Mishkin S Dig Dis Sci; 1981 Nov; 26(11):1045-50. PubMed ID: 6271517 [TBL] [Abstract][Full Text] [Related]
2. Liver tumor in long-term user of oral contraceptives. Ferrara BE; Rutland ED Postgrad Med; 1988 Nov; 84(6):107-9. PubMed ID: 2847128 [TBL] [Abstract][Full Text] [Related]
3. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia]. Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901 [TBL] [Abstract][Full Text] [Related]
4. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Gyorffy EJ; Bredfeldt JE; Black WC Ann Intern Med; 1989 Mar; 110(6):489-90. PubMed ID: 2537593 [TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives and focal nodular hyperplasia of the liver. Hagay ZJ; Leiberman RJ; Katz M; Witznitzer A Arch Gynecol Obstet; 1988; 243(4):231-4. PubMed ID: 3223780 [TBL] [Abstract][Full Text] [Related]
6. Hepatic adenoma within a spindle cell carcinoma in a woman with a long history of oral contraceptives. Grigsby P; Meyer JS; Sicard GA; Huggins MB; Lamar DJ; DeSchryver-Kecskemeti K J Surg Oncol; 1987 Jul; 35(3):173-9. PubMed ID: 2439848 [TBL] [Abstract][Full Text] [Related]
7. Severe and prolonged oral contraceptive jaundice. Lieberman DA; Keeffe EB; Stenzel P J Clin Gastroenterol; 1984 Apr; 6(2):145-8. PubMed ID: 6715853 [TBL] [Abstract][Full Text] [Related]
8. Possible association between benign hepatomas and oral contraceptives. Baum JK; Bookstein JJ; Holtz F; Klein EW Lancet; 1973 Oct; 2(7835):926-9. PubMed ID: 4126557 [TBL] [Abstract][Full Text] [Related]
9. Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives. van Erpecum KJ; Janssens AR; Kreuning J; Ruiter DJ; Kroon HM; Grond AJ Am J Gastroenterol; 1988 May; 83(5):572-5. PubMed ID: 3129933 [TBL] [Abstract][Full Text] [Related]
10. [Spontaneous regression of a large liver tumor with markedly elevated serum enzyme levels]. Siegel EG; Hartmann H Z Gastroenterol; 1987 Dec; 25(12):764-8. PubMed ID: 2830733 [TBL] [Abstract][Full Text] [Related]
11. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1982. Tender hepatomegaly in a 29-year-old woman. N Engl J Med; 1982 Oct; 307(15):934-42. PubMed ID: 7110274 [TBL] [Abstract][Full Text] [Related]
12. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Bühler H; Pirovino M; Akobiantz A; Altorfer J; Weitzel M; Maranta E; Schmid M Gastroenterology; 1982 Apr; 82(4):775-82. PubMed ID: 6277724 [TBL] [Abstract][Full Text] [Related]
13. Liver-cell adenoma. Case report. Christensen M; Støckel M; Balslev I Acta Chir Scand; 1986 Oct; 152():633-5. PubMed ID: 3028021 [TBL] [Abstract][Full Text] [Related]
14. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel. Lemay A; Dewailly SD; Grenier R; Huard J J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494 [TBL] [Abstract][Full Text] [Related]
15. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. Notelovitz M; Kitchens CS; Khan FY Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974 [TBL] [Abstract][Full Text] [Related]
16. Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review. Korba VD; Heil CG Fertil Steril; 1975 Oct; 26(10):973-81. PubMed ID: 1183625 [TBL] [Abstract][Full Text] [Related]
17. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821 [TBL] [Abstract][Full Text] [Related]
19. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Gordon SC; Reddy KR; Livingstone AS; Jeffers LJ; Schiff ER Ann Intern Med; 1986 Oct; 105(4):547-9. PubMed ID: 3019201 [TBL] [Abstract][Full Text] [Related]